Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    87,368.14
    +2,089.46 (+2.45%)
     
  • CMC Crypto 200

    1,367.31
    +54.68 (+4.17%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News for Dec 28, 2020

  • Shares of Anheuser-Busch InBev SA/NV BUD rose 0.1% following news that the company has agreed to sell 49.9% stake in its U.S. metal container plants for nearly $3 billion to a consortium led by Apollo Global Management, Inc. APO.

  • Inovio Pharmaceuticals Inc. INO shares gained 1.9% after the company released positive Phase 1 data of its COVID-19 DNA vaccine candidate.

  • Shares of Alphabet Inc. GOOGL advanced 0.3% following news that Google is partnering with Saudi Aramco for providing cloud services in Saudi Arabia.

  • Intel Corp. INTC shares gained 1.1% after Cloudera Inc. CLDR said that it repurchased all of Intel’s stake in the company for $314 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Intel Corporation (INTC) : Free Stock Analysis Report
 
AnheuserBusch InBev SANV (BUD) : Free Stock Analysis Report
 
Apollo Global Management, Inc. (APO) : Free Stock Analysis Report
 
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
 
Inovio Pharmaceuticals, Inc. (INO) : Free Stock Analysis Report
 
Cloudera, Inc. (CLDR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research